IndraLab

Statements


| 11

reach
"Among the tested flavones, 7,8-DHF, quercetin, and apigenin reduced Tau aggregation, oxidative stress, and caspase-1 activity as well as improved neurite outgrowth in SH-SY5Y cells expressing ΔK280 Tau RD -DsRed folding reporter."

reach
"Employing Aβ folding reporter SH-SY5Y cells, we showed that quercetin and apigenin reduced Aβ-aggregation, oxidative stress, caspase-1 and acetylcholinesterase activities, as well as improved the neurite outgrowth."

reach
"The current study proved for the first time that quercetin treatment remarkably inhibited hypothalamic NLRP3 and caspase-1 in high fructose fed rats, being consistent with the reduction of hypothalami[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Simultaneously, the treatment of quercetin at 50 and 100 mg/kg, as well as allopurinol at 5 mg/kg, remarkably reduced maturation of caspase-1 (quercetin and allopurinol : P <.001) and IL-1beta (querce[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Western blot analysis indicates that LPS treatment induced degradation of caspase-1 precursor, which was inhibited by treatment CYT or quercetin."

reach
"In conclusion, we suggest that CYT and quercetin decrease LPS induced inflammatory cytokine production by inhibiting NF-kappaB and caspase-1 activation."

reach
"CYT and quercetin also inhibited IL-32 production and caspase-1 activation."

reach
"To determine if CYT or quercetin inhibits caspase-1 activation induced by LPS, cells were exposed to LPS in the presence or absence of CYT (1 mg/ml) or quercetin (0.1 mM)."

reach
"In addition, quercetin reduced Caspase-1 activity observed in LPS plus nigericin (XREF_FIG)."

reach
"Quercetin significantly inhibited BCRD-induced neuron pyroptosis via downregulation of PYD and card domain containing (ASC), NLR family pyrin domain containing 3 (NLRP3), and caspase-1, and quercetin could reverse BCRD-caused inhibition of neuron viability."

reach
"Subsequently, Caspase-1 inhibition by quercetin and allopurinol prevented kidney IL-1beta and IL-18 release and over-production triggered by hyperuricemia and dyslipidemia in this model."